Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 156.63M P/E - EPS this Y -69.00% Ern Qtrly Grth -
Income -58.34M Forward P/E -3.42 EPS next Y -40.10% 50D Avg Chg 5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 1.47 EPS next 5Y - 52W High Chg -47.00%
Recommedations 1.40 Quick Ratio 10.72 Shares Outstanding 63.81M 52W Low Chg 137.00%
Insider Own 1.45% ROA -23.59% Shares Float 31.93M Beta 0.77
Inst Own 108.07% ROE -37.48% Shares Shorted/Prior 3.33M/3.63M Price 3.62
Gross Margin - Profit Margin - Avg. Volume 363,732 Target Price 22.14
Oper. Margin - Earnings Date Nov 12 Volume 214,145 Change -11.06%
About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.

Larimar Therapeutics, Inc. News
11/18/24 Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
10/30/24 Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
10/17/24 Companies Like Larimar Therapeutics (NASDAQ:LRMR) Are In A Position To Invest In Growth
09/19/24 Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Congress for Ataxia Research
08/27/24 Larimar Therapeutics to Participate in Upcoming Investor Conferences
08/07/24 Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
07/30/24 Bullish Larimar Therapeutics Insiders Loaded Up On US$540.7k Of Stock
05/30/24 Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
05/20/24 Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
05/09/24 Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
03/14/24 Larimar Therapeutics Inc (LRMR) Reports Full Year and Q4 2023 Financial Results
03/14/24 Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
03/11/24 Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
03/06/24 Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
02/16/24 Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
02/14/24 Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
02/13/24 Larimar Therapeutics Announces Proposed Underwritten Public Offering
02/12/24 Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia
12/09/23 With 45% ownership, Larimar Therapeutics, Inc. (NASDAQ:LRMR) has piqued the interest of hedge funds investors
LRMR Chatroom

User Image HoHoHoHum Posted - 16 hours ago

$LRMR just trying to do some dd before deciding to enter. This company is working on a treatment for Friedreichs ataxia a rare genetic disease with 20000 patients worldwide. How much big can this really get treating a rare disease like that? What is there to get excited about? What am i missing? Just seeking serious opinions and information. Not bashing.

User Image Alexggtrader Posted - 2 days ago

$LRMR Wedbush’s most recent take on yesterday’s data. Target price of $22 is reiterated. Positive update in December will move the stock sharply higher. Major institutions (including Goldman Sachs) recently took a large position. Everyone should conduct their due diligence.

User Image Thestocktraderhubzee Posted - 2 days ago

WATCHLIST NOV 19 2024. $FNV UBS Initiates Coverage On Franco-Nevada with Buy Rating, Announces Price Target of $160 $LRMR HC Wainwright & Co. Reiterates Buy on Larimar Therapeutics, Maintains $15 Price Target $DIN Piper Sandler Maintains Neutral on Dine Brands Global, Lowers Price Target to $38 $AHR RBC Capital Maintains Outperform on American Healthcares, Raises Price Target to $30 $HUMA HC Wainwright & Co. Reiterates Buy on Humacyte, Maintains $12 Price Target

User Image BiotechStockFundManager Posted - 3 days ago

$LRMR and $CRVS are my top 2 picks going into the end of the year. Both have major catalysts in mid-December.

User Image WarrenPsnik Posted - 3 days ago

$LRMR Forgot to mention … Added more at $6.06.

User Image BiotechStockFundManager Posted - 3 days ago

$LRMR Hold onto your shares. Downside from here is limited. Upside is massive.

User Image WarrenPsnik Posted - 3 days ago

$LRMR Only news I could find. They remain on track for mid-December results report. https://www.globenewswire.com/news-release/2024/11/18/2982603/0/en/Larimar-Therapeutics-Presents-Additional-Data-from-Phase-1-Studies-and-Phase-2-Dose-Exploration-Study-Supporting-the-Nomlabofusp-Clinical-Program-at-ICAR-2024.html

User Image cjstocks25 Posted - 3 days ago

$LRMR did this thing die

User Image kenny91655 Posted - 3 days ago

$LRMR Low 6's. Buying

User Image pc247cz Posted - 5 days ago

$ADVM $CABA $IOVA $LPTX $LRMR Monday morning 😉 Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements

User Image kenny91655 Posted - 6 days ago

$LRMR Look what happened to LXEO in last 20 minutes

User Image kenny91655 Posted - 6 days ago

$LRMR Up to 10k shares. Started at 7. May dip to low 6's again

User Image Stock1701 Posted - 6 days ago

$LRMR Days like this is when you’re suppose to buy. Selling on a red day is what the hedge funds want. Adding another bit more to round up my hold. Holding now 1k shares.

User Image BiotechStockFundManager Posted - 6 days ago

$LRMR I am a buyer today.

User Image pc247cz Posted - 6 days ago

$ADVM $CABA $IOVA $LPTX $LRMR Sorry, but... Out of all due to market weakness. Except $ADVM still holding and prepared to add more if it drops further.

User Image Stock1701 Posted - 6 days ago

$LRMR Adding a bit more, insti. Ownership at 99.99%. If results are good this gets bought out.

User Image Stock1701 Posted - 1 week ago

$LRMR Added, thanks for the dip.

User Image Bulltrader988 Posted - 1 week ago

$LRMR cool off was needed, look at the weekly chart

User Image ronaldo7 Posted - 1 week ago

$LRMR

User Image Bulltrader988 Posted - 1 week ago

$LRMR maybe more eyes on this next week: "Larimar will present three posters during the conference, one of which will also be presented as an oral presentation. The poster presentations are as follows: Effect of nomlabofusp administration on tissue frataxin levels, plasma lipid profiles, and gene expression in patients with Friedreich’s ataxia Oral presentation by Dr. Russell Clayton, Chief Medical Officer of Larimar Therapeutics on Thursday November 14, 2024, at 5:07 PM CT Disease characteristics and tissue frataxin concentrations in adults with Friedreich’s ataxia participating in nomlabofusp interventional studies Prediction of tissue frataxin levels with long term administration of nomlabofusp in adults with Friedreich’s ataxia using modeling and simulations" https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-three-poster-presentations

User Image Bulltrader988 Posted - 1 week ago

$LRMR nice and now the 6 months high at $10.68

User Image Ace_AP Posted - 2 weeks ago

$LRMR caught a nice dip here. Gonna load up January $12.5s

User Image hope_my_calls_print Posted - 2 weeks ago

$LRMR Funds are gonna be trying to accumulate into data. Still plenty of room up from here.

User Image Bulltrader988 Posted - 2 weeks ago

$LRMR break that $9

User Image Bulltrader988 Posted - 2 weeks ago

$LRMR amazing day and the next few weeks should be more amazing

User Image BiotechStockFundManager Posted - 2 weeks ago

$LRMR I accumulated more shares this week. Why? Greatly undervalued.

User Image cjstocks25 Posted - 2 weeks ago

$LRMR what happened here?

User Image Bulltrader988 Posted - 2 weeks ago

$LRMR holding strong

User Image Quantumup Posted - 10/31/24

Citi opened a "90-day positive catalyst watch" on $LRMR reit Buy; $14. Citi says ahead of Dec🔬, they're opening a +VE 90-day🐈Watch—it sees pot⬆️side for shares on confirmation of a favorable safety profile, durable frataxin increases /early trends for +VE outcomes data: $biib $reta

User Image Bulltrader988 Posted - 10/31/24

$LRMR https://www.benzinga.com/quote/LRMR/analyst-ratings

Analyst Ratings
HC Wainwright & Co. Buy Oct 2, 24
Jones Trading Buy Sep 12, 24
Baird Outperform Sep 4, 24
JMP Securities Market Outperform May 31, 24
Citigroup Buy May 22, 24
JMP Securities Market Outperform May 21, 24
Leerink Partners Outperform Apr 3, 24
JMP Securities Market Outperform Mar 15, 24
JMP Securities Market Outperform Mar 12, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Celano Michael Chief Financial Offi.. Chief Financial Officer May 17 Buy 3.7263 5,000 18,632 112,746 05/18/23
BEN-MAIMON CAROLE President and CEO President and CEO May 17 Buy 3.705 5,000 18,525 266,829 05/18/23
Truitt Joseph Director Director May 17 Buy 3.73 2,750 10,258 2,750 05/18/23
Flynn James E - - Sep 16 Buy 3.15 11,111,108 34,999,990 2,777,777 09/20/22
Hamilton Thomas Edward Director Director Sep 16 Buy 3.15 317,460 999,999 507,590 09/20/22
Celano Michael Chief Financial Offi.. Chief Financial Officer Sep 16 Buy 3.15 31,746 100,000 31,746 09/19/22
BEN-MAIMON CAROLE President and CEO President and CEO Sep 16 Buy 3.15 31,746 100,000 56,829 09/19/22